Laboratory Animal Research · 2016 · 24 citations · 17 references
Life SciencesImmunologyPharmacologyImmunopathologyImmunoregulationInflammationGastrointestinal InflammationGut MicrobiotaInflammatory Bowel DiseaseIntestinal Barrier FunctionMucosal Barrier FunctionMucosal InflammationAnti-inflammatory ActivityInflammation-induced Barrier DisruptionInflammation-related Barrier DysfunctionInflammatory Bowel Disease TherapyIntestinal Barrier IntegrityIntestinal Barrier PermeabilityIntestinal Epithelial Barrier FunctionTraditional Herbal Medicine
. As the mice or intestinal epithelial cells were treated with DSS/fPue, mRNA expression of pro-inflammatory cytokines was reduced and the architecture and expression of tight junction proteins were recovered, compared to the DSS-treated group. In summary, fPue treatment resulted in amelioration of DSS-induced inflammation in the colon, and the disrupted intestinal barrier was recovered as the expression and architecture of tight junction proteins were retrieved. These results suggest that use of fPue could be a new therapeutic strategy for treatment of IBD.
17
H-C REINECKER, Martín Steffen, T. Witthoeft et al. · Clinical & Experimental Immunology · 1993 · 861 citations · Full text
Life Sciences, Immunology, Pathology +17